Antihistamines and similar drugs could slow down Huntington’s disease
Scientists have described a potential new therapeutic strategy for slowing down early-stage Huntington’s disease in a new study published today in eLife.
Latest
- UMD-led study shows fear and anxiety share same bases in brain
- Patients who had more severe covid-19 may be the best donors for convalescent plasma therapy
- Astrophysics team lights the way for more accurate model of the universe
- Tropical cyclones moving faster in recent decades
- Untreated sleep apnea is associated with flu hospitalization